These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8422695)

  • 1. Antitumor activity of the aromatase inhibitor FCE 24928 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Zaccheo T; di Salle E
    Cancer Chemother Pharmacol; 1993; 31(4):308-12. PubMed ID: 8422695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Zaccheo T; Di Salle E
    Cancer Chemother Pharmacol; 1989; 25(2):95-8. PubMed ID: 2513137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
    Zaccheo T; Giudici D; Lombardi P; di Salle E
    Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
    Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats.
    Zaccheo T; Giudici D; Di Salle E
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):677-80. PubMed ID: 8476783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
    De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
    Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
    Zaccheo T; Giudici D; Ornati G; Panzeri A; di Salle E
    Eur J Cancer; 1991; 27(9):1145-50. PubMed ID: 1835626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
    Nishino Y; Schneider MR; Michna H; el Etreby MF
    J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Tanaka M; Yano S; Hasegawa Y; Nakao K
    Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
    Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
    Van Ginckel R; Janssens B; Callens M; Goeminne N; Wouters L; De Coster R
    Cancer Chemother Pharmacol; 1996; 38(1):21-8. PubMed ID: 8603447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
    Zaccheo T; Casazza AM; di Salle E; Pollini C; di Marco A
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1193-7. PubMed ID: 6236980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new aromatase inhibitor, FR901537. II. Pharmacological and antitumor effects.
    Oohata N; Kawamura I; Lacey E; Nishigaki F; Matsumoto S; Tsujimoto S; Naoe Y; Manda T; Shimomura K
    J Antibiot (Tokyo); 1995 Aug; 48(8):763-7. PubMed ID: 7592018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
    Cos S; González A; Güezmes A; Mediavilla MD; Martínez-Campa C; Alonso-González C; Sánchez-Barceló EJ
    Int J Cancer; 2006 Jan; 118(2):274-8. PubMed ID: 16080194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.
    Schieweck K; Bhatnagar AS; Batzl C; Lang M
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):633-6. PubMed ID: 8476774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer.
    Li S; Martel C; Dauvois S; Bélanger A; Labrie F
    Endocrinology; 1994 Mar; 134(3):1352-7. PubMed ID: 8119175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N; Koibuchi Y; Iino Y; Morishita Y
    Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.